Coordinatore | CONSIGLIO NAZIONALE DELLE RICERCHE
Organization address
address: Piazzale Aldo Moro 7 contact info |
Nazionalità Coordinatore | Italy [IT] |
Sito del progetto | http://www.escardio.org/communities/Working-Groups/nuclear-cardiology/Pages/EVINCIStudy.aspx |
Totale costo | 3˙432˙418 € |
EC contributo | 2˙695˙402 € |
Programma | FP7-HEALTH
Specific Programme "Cooperation": Health |
Code Call | FP7-HEALTH-2007-B |
Funding Scheme | CP-FP |
Anno di inizio | 2009 |
Periodo (anno-mese-giorno) | 2009-01-01 - 2012-06-30 |
# | ||||
---|---|---|---|---|
1 |
CONSIGLIO NAZIONALE DELLE RICERCHE
Organization address
address: Piazzale Aldo Moro 7 contact info |
IT (ROMA) | coordinator | 632˙071.00 |
2 |
TURUN YLIOPISTO
Organization address
address: YLIOPISTONMAKI contact info |
FI (TURUN YLIOPISTO) | participant | 450˙023.10 |
3 |
Nome Ente NON disponibile
Organization address
address: via Trieste 41 contact info |
IT (Pisa) | participant | 233˙031.84 |
4 |
ACADEMISCH ZIEKENHUIS LEIDEN
Organization address
address: Albinusdreef 2 contact info |
NL (LEIDEN) | participant | 199˙115.02 |
5 |
QUEEN MARY UNIVERSITY OF LONDON
Organization address
address: 327 MILE END ROAD contact info |
UK (LONDON) | participant | 120˙247.88 |
6 |
UNIVERSITA DEGLI STUDI DI GENOVA
Organization address
address: VIA BALBI 5 contact info |
IT (GENOVA) | participant | 112˙821.36 |
7 |
SERVICIO MADRILENO DE SALUD
Organization address
address: PLAZA CARLOS TRIAS BERTRAN 7 contact info |
ES (MADRID) | participant | 107˙893.24 |
8 |
KLINIKUM RECHTS DER ISAR DER TECHNISCHEN UNIVERSITAT MUNCHEN
Organization address
address: ISMANINGER STRASSE 22 contact info |
DE (MUENCHEN) | participant | 98˙962.99 |
9 |
ROYAL BROMPTON AND HAREFIELD NATIONAL HEALTH SERVICE TRUST
Organization address
address: SYDNEY STREET contact info |
UK (LONDON) | participant | 95˙272.12 |
10 |
UNIVERSITAET ZUERICH
Organization address
address: Raemistrasse 71 contact info |
CH (ZURICH) | participant | 92˙706.00 |
11 |
INSTYTUT KARDIOLOGII IM. PRYMASA TYSIACLECIA STEFANA KARDYNALA WYSZYNSKIEGO
Organization address
address: ul. Alpejska 42 contact info |
PL (WARSZAWA) | participant | 89˙980.81 |
12 |
ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS
Organization address
address: 3 Avenue Victoria contact info |
FR (PARIS) | participant | 84˙513.16 |
13 |
CF CONSULTING FINANZIAMENTI UNIONE EUROPEA SRL
Organization address
address: Via Giuseppe Mussi 1 contact info |
IT (MILANO) | participant | 79˙661.10 |
14 |
INSTITUT CATALA DE LA SALUT
Organization address
address: GRAN VIA DE LES CORTS CATALANES 587 contact info |
ES (BARCELONA) | participant | 56˙265.54 |
15 |
INFORSENSE LIMITED
Organization address
address: HAMMERSMITH ROAD COLET COURT 100 contact info |
UK (London) | participant | 46˙740.90 |
16 |
UNIVERSITA DEGLI STUDI DI NAPOLI FEDERICO II.
Organization address
address: Corso Umberto I 40 contact info |
IT (NAPOLI) | participant | 45˙032.36 |
17 |
ALB FILS KLINIKEN GMBH
Organization address
address: EICHERTSTRASSE 3 contact info |
DE (GOPPINGEN) | participant | 40˙000.00 |
18 |
AZIENDA OSPEDALIERO-UNIVERSITARIA CAREGGI
Organization address
address: via delle Oblate 1 contact info |
IT (FIRENZE) | participant | 40˙000.00 |
19 |
Azienda U.S.L. N. 12 di Viareggio
Organization address
address: Via Aurelia 335 contact info |
IT (Lucca) | participant | 30˙000.00 |
20 |
SOCIETE EUROPEENNE DE CARDIOLOGIE
Organization address
address: ROUTE DES COLLES 2035 contact info |
FR (BIOT SOPHIA ANTIPOLIS) | participant | 28˙180.00 |
21 |
FUNDACIO PRIVADA INSTITUT DE RECERCA DE L'HOSPITAL DE LA SANTA CREU I SANT PAU
Organization address
address: CALLE SANT ANTONI M CLARET 167 contact info |
ES (BARCELONA) | participant | 12˙883.59 |
22 |
TECHNISCHE UNIVERSITAET MUENCHEN
Organization address
address: Arcisstrasse 21 contact info |
DE (MUENCHEN) | participant | 0.00 |
Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.
'The main purpose of the EVINCI-study is to test the impact of combined “anatomo-functional” non invasive cardiac imaging for detection and characterization of Ischemic Heart Disease (IHD). The EVINCI-study is a prospective clinical European multicenter trial performed in a cohort of 700 patients with suspected IHD. Patients with intermediate pre-test probability will undergo clinical and biohumoral characterization, including novel circulating markers of cardiovascular risk. They will be admitted to a non-invasive cardiac evaluation, consisting of “anatomic” imaging, by multislice computerized tomography, combined with “functional” tests among radionuclide, magnetic resonance and ultrasound imaging. Heart catheterization will be performed to validate non-invasive diagnosis and follow-up to assess outcome. The diagnostic accuracy of combined non-invasive “anatomo-functional” imaging will be tested against reference methods for diagnosing epicardial coronary lesions (coronary angiography), vessel wall atherosclerosis (intracoronary ultrasound) and impaired coronary flow reserve (intracoronary doppler/pressure wire). The individual profiles from “anatomo-functional” cardiac imaging and “clinical-biohumoral” data will be combined and tested against outcome. A cost-benefit analysis (including an estimate of procedural/radiological risks) of the new diagnostic work-up will also be performed. A relevant part of the EVINCI-study will be dedicated to the development, in cooperation with the industry, of an advanced informatics’ platform able to synthetically present to the end-user (patients, physicians, etc.) the integrated cardiological diagnostic profile of the individual patient as resulting from clinical-biohumoral and multi-imaging assessment. Overall results will be disseminated in cooperation with the European Society of Cardiology (ESC) and will guide the work of a dedicated ESC Commission which will release specific European Recommendations.'
A recent study evaluated an integrated non-invasive cardiac imaging technique for the detection of ischaemic heart disease (IHD).
Cardiovascular disease is a major cause of death across Europe. Although cardiovascular mortality rates, adjusted for age, are generally declining, the prevalence of IHD is increasing due to the emergence of new risk factors.
In order to further reduce cardiovascular mortality and morbidity, better prevention and management of IHD is needed. A common technique for the diagnosis of IHD is invasive coronary angiography, but its current diagnostic yeld is suboptimal mainly due to underutilization of non-invasive tests prior to the invasive study.
The EU-funded EVINCI-STUDY project investigated the diagnostic accuracy of combining non-invasive anatomical information from computed tomography coronary angiography (CTCA) with functional information from stress imaging. The aim is to achieve earlier non-invasive detection and characterisation and thus better management of IHD. Project partners performed the investigations in a cohort of 697 patients with suspected IHD, and low-intemediate probability of disease, selected from 14 clinical centres across Europe.
Comparison of several imaging techniques for their diagnostic accuracy to detect obstructive coronary disease and predict revascularization revealed that CTCA had better diagnostic performance than stress imaging. Perfusion based imaging techniques (Single-photon emission computed tomography (SPECT) and positron emission tomography (PET)) had greater sensitivity, while wall motion based techniques (echocardiogram (ECHO) and cardiac magnetic resonance (CMR)) had greater specificity. In addition, integration of CTCA with functional imaging increased diagnostic accuracy of functional imaging alone.
Project members implemented a multimodal electronic tool to enable the organisation and visualization of all available information (clinical, biological and cardiac imaging) for a single patient. This ensured easy presentation of the integrated information at multiple levels of complexity to specialists and referring physicians, including medical practitioners.
In years to come, there will hopefully be a reduction in the use of invasive procedures, inappropriate revascularisation and health costs due to poor management. In addition, early detection could promote prevention and early treatment programmes.